One of the remarkable turnaround stories during the COVID-19 pandemic, biotechnology specialist Novavax (NVAX) has struggled ...

The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms ...

In early May 2026, Novavax reported first-quarter revenue of US$139.51 million versus US$666.66 million a year earlier, swinging from net income of US$518.65 million to a net loss of US$9.49 million ...

Shares of Moderna (NASDAQ:MRNA) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday’s close ...

Novavax on Wednesday beat Wall Street estimates for first-quarter revenue, as milestone payments from vaccine ​supply and ...

Moderna Inc. MRNA and Novavax Inc. NVAX shares moved higher Monday as traders piled back into vaccine names following renewed ...

Novavax's business has improved over the past 18 months. The company has several important catalysts and potential growth drivers. The biotech remains a relatively risky stock pick. However, a lot has ...

Novavax received emergency use authorization for an updated vaccine. The biotech is benefiting from a partnership with Sanofi. However, its prospects remain unpredictable. Though we are no longer in a ...

Quote (Executive VP, CFO & Treasurer Kelly): “Nuvaxovid product sales of $10 million was primarily driven by sales into Germany for the 2025-2026 season and reflects the completion of Novavax’s ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica was a writer on the Wellness team, with a focus on health ...

Novavax (NVAX) is in focus after outlining a move toward a licensing and royalty model, supported by partnerships with Sanofi and Pfizer, while investors watch for a Phase 3 COVID influenza combo ...

Add Yahoo as a preferred source to see more of our stories on Google. Novavax, sold under the brand name Nuvaxovid, is a protein-based COVID-19 vaccine — the same technology used to develop many other ...